THE TRIALS IN THE UK AND SOUTH AFRICA MEANT NOVAVAX IS THE FIRST TO TEST A VACCINE AGAINST THE NEW SARS-COV2 VARIANTS FIRST IDENTIFIED IN THESE COUNTRIES.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
